Darya-Varia Laboratoria Tbk PT
IDX:DVLA
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Celanese Corp
NYSE:CE
|
Chemicals
|
| US |
|
General Mills Inc
NYSE:GIS
|
Food Products
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
Lowe's Companies Inc
NYSE:LOW
|
Retail
|
| US |
|
Lennar Corp
NYSE:LEN
|
Consumer products
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
Citigroup Inc
NYSE:C
|
Banking
|
| US |
|
Goodyear Tire & Rubber Co
NASDAQ:GT
|
Auto Components
|
| US |
|
Intel Corp
NASDAQ:INTC
|
Semiconductors
|
| US |
|
Starbucks Corp
NASDAQ:SBUX
|
Hotels, Restaurants & Leisure
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 390
1 810
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Celanese Corp
NYSE:CE
|
US |
|
|
General Mills Inc
NYSE:GIS
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
Lowe's Companies Inc
NYSE:LOW
|
US |
|
|
Lennar Corp
NYSE:LEN
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
Citigroup Inc
NYSE:C
|
US |
|
|
Goodyear Tire & Rubber Co
NASDAQ:GT
|
US |
|
|
Intel Corp
NASDAQ:INTC
|
US |
|
|
Starbucks Corp
NASDAQ:SBUX
|
US |
This alert will be permanently deleted.
Darya-Varia Laboratoria Tbk PT
Darya-Varia Laboratoria Tbk PT
Current Portion of Long-Term Debt
Darya-Varia Laboratoria Tbk PT
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Current Portion of Long-Term Debt
Rp443.6m
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
-34%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Current Portion of Long-Term Debt
Rp37.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
18%
|
CAGR 10-Years
50%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Current Portion of Long-Term Debt
Rp79.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Current Portion of Long-Term Debt
Rp10.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Current Portion of Long-Term Debt
Rp66.4B
|
CAGR 3-Years
111%
|
CAGR 5-Years
147%
|
CAGR 10-Years
28%
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Current Portion of Long-Term Debt
Rp1.1T
|
CAGR 3-Years
12%
|
CAGR 5-Years
54%
|
CAGR 10-Years
91%
|
|
Darya-Varia Laboratoria Tbk PT
Glance View
PT Darya-Varia Laboratoria Tbk engages in the manufacture and trade of pharmaceutical products and cosmetics. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,274 full-time employees. Its segments include prescription drugs, consumer health products, and export and toll manufacturing services. The firm provides products and services for consumer health, skin nutrition, respiratory, vitamins and daily relief. The Company’s products include Remscar (silicone gel), Carvilol, Ondavar (antiemetic), Etorix, Forti-D (vitamin D supplement), Decolgen, Neozep, Stop Cold, Decolsin, and Allerin. The Carvilol is used for heart health and treating hypertension. Ondavar is an antiemetic product used for nausea and vomiting during pregnancy. Etorix is a pain reliever. Forti-D is a supplement to fulfill the body’s need for vitamin D3. Darya-Varia provides a range of brands such as Enervon-C, Enervon Active, and Supertin that helps to boost body immune and maintain health. The firm also provides Imunped as supplement for kids with Zinc and vitamin C for children.
See Also
What is Darya-Varia Laboratoria Tbk PT's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
443.6m
IDR
Based on the financial report for Sep 30, 2024, Darya-Varia Laboratoria Tbk PT's Current Portion of Long-Term Debt amounts to 443.6m IDR.
What is Darya-Varia Laboratoria Tbk PT's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
-34%
Over the last year, the Current Portion of Long-Term Debt growth was 4%. The average annual Current Portion of Long-Term Debt growth rates for Darya-Varia Laboratoria Tbk PT have been -77% over the past three years , -61% over the past five years , and -34% over the past ten years .
You don't have any saved screeners yet
